| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/1997 | US5668110 Peptides and compounds that bind to the IL-5 receptor |
| 09/16/1997 | US5668109 Peptides for inhibiting pepsin release |
| 09/16/1997 | US5668108 Preparation of functional human factor VIII and pharmaceutical treatment therewith |
| 09/16/1997 | US5668107 Polypeptide bonded to extracellular matrix protein |
| 09/16/1997 | US5668106 Method and compositions for making ACSF and ACSF antagonists |
| 09/16/1997 | US5668105 Aza cyclohexapeptide compounds |
| 09/16/1997 | US5668104 Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo |
| 09/16/1997 | US5668013 Antigen recognized by patients with antibody associated paraneoplastic cerebellar degeneration, DNA encoding same and uses thereof |
| 09/16/1997 | US5668012 Platelet endothelial cell adhesion molecule-1 promoters and uses thereof |
| 09/16/1997 | US5668003 Nucleic acid encoding monoclonal antibodies to leukemia inhibitory factor |
| 09/16/1997 | US5668002 DNA and polypeptide for tumor-associated antigen CO-029 |
| 09/16/1997 | US5667992 Mammalian expression systems for HCV proteins |
| 09/16/1997 | US5667991 Recombinant mersacidin and a method for production |
| 09/16/1997 | US5667989 Fungal cell wall Protein CLY4 |
| 09/16/1997 | US5667988 Gene expression and genes with antibodies and antigens |
| 09/16/1997 | US5667987 P53 response genes |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667978 Antibody to the neural cell adhesion molecule and methods of use |
| 09/16/1997 | US5667969 Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing |
| 09/16/1997 | US5667968 Prevention of retinal injury and degeneration by specific factors |
| 09/16/1997 | US5667965 Papillomavirus E2 trans-activation repressors |
| 09/16/1997 | US5667811 Na-K-ATPase inhibiting natriuretic substances |
| 09/16/1997 | US5667810 Method of accelerating the healing of bone and cartilage tissue with cytokines |
| 09/16/1997 | US5667808 Metal ion complex |
| 09/16/1997 | US5667797 Anti-viral composition and kit and use for treating rotavirus infection and diarrhea |
| 09/16/1997 | US5667791 X-ray induced skin damage protective composition |
| 09/16/1997 | US5667786 Method for treating tumors with a toxin |
| 09/16/1997 | US5667781 Enhanced inhibition of tumor cell proliferation using a combination of two monoclonal antibodies to the human transferrin receptor |
| 09/16/1997 | US5667780 Sensory and motor neuron derived factor and binding |
| 09/16/1997 | US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase |
| 09/16/1997 | US5667776 Anticarcinogenic agents, treatment of infectious diseases and damage from radiation or chemotherapy |
| 09/16/1997 | US5667491 Method for rapid temporal control of molecular transport across tissue |
| 09/16/1997 | CA2011008C Egf variants and pharmaceutical use thereof |
| 09/16/1997 | CA1339464C ¬leu13| motilin, dnas coding for same and methods for producing same |
| 09/15/1997 | CA2200032A1 Axial length control agent and agent for prophylaxis and treatment of myopia or hyperopia |
| 09/15/1997 | CA2199888A1 Method for improving morbidity and/or mortality |
| 09/12/1997 | WO1997033175A1 Process for diagnosing alzheimer's disease and agents for use in therapy |
| 09/12/1997 | WO1997033174A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/12/1997 | WO1997033173A1 Muscular dystrophy, stroke, and neurodegenerative disease diagnosis and treatment |
| 09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
| 09/12/1997 | WO1997032993A1 Chemotactic cytokine iii |
| 09/12/1997 | WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032984A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 09/12/1997 | WO1997032981A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032978A1 Production of human hemoglobin in transgenic animals |
| 09/12/1997 | WO1997032973A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 09/12/1997 | WO1997032898A1 Anti-inflammatory crf analogs, their compositions and use |
| 09/12/1997 | WO1997032896A1 Antitumor substance extracted from hen-of-the-woods |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032893A1 Purification method |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032860A1 Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors |
| 09/12/1997 | WO1997032654A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032605A1 Cytomegalovirus nucleic acids encoding proteins having normal or altered class i mhc binding and treatment of diseases |
| 09/12/1997 | WO1997032602A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF |
| 09/12/1997 | WO1997032601A1 Method of screening apoptosis inducing substances |
| 09/12/1997 | WO1997032600A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/12/1997 | WO1997032597A1 Method and composition for the treatment of osteoarthritis |
| 09/12/1997 | WO1997032596A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | WO1997032595A1 Method for treatment of insulin resistance |
| 09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | WO1997032591A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | WO1997032580A1 3-substituted-4-oxa-1-azabicyclo[3,2,0]heptan-7-one as cysteine protease inhibitors |
| 09/12/1997 | WO1997032572A2 Materials and methods for enhancing cellular internalization |
| 09/12/1997 | WO1997032571A1 Functionalized nanotubes |
| 09/12/1997 | WO1997032541A1 Angiogenic lipid formulations |
| 09/12/1997 | WO1997032480A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | WO1997026320A3 Product for inhibition of attachment of h. influenzae to human cells |
| 09/12/1997 | WO1997025421A3 PROTEIN INDUCED BY DEPRENYL$m(3) |
| 09/12/1997 | WO1997024436A3 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use |
| 09/12/1997 | WO1997023624A3 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | WO1997022690A3 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) |
| 09/12/1997 | WO1997021826A3 Complementary adenoviral vector systems and cell lines |
| 09/12/1997 | WO1997012636A3 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes |
| 09/12/1997 | WO1997011690A3 Inhibitors of regulatory pathways |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | WO1997004097A3 Human CTLA-8 and uses of CTLA-8-related proteins |
| 09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
| 09/12/1997 | CA2248233A1 Delivery system using mab 3e10 and mutants and/or functional fragments thereof |
| 09/12/1997 | CA2248078A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/12/1997 | CA2248065A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | CA2247817A1 Filtration of plasma mixtures using cellulose-based filter aids |
| 09/12/1997 | CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | CA2247615A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | CA2244894A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | CA2220222A1 Angiogenic lipid formulations |
| 09/11/1997 | DE19608519A1 Diagnosing Alzheimer's disease from level of apoptosis in peripheral blood cells |
| 09/11/1997 | DE19608229A1 Use of thymotrinan and thymocartin in medicaments |
| 09/10/1997 | EP0794195A2 Antibody BV10A4H2 |
| 09/10/1997 | EP0793966A1 Cyclosporin-containing topical pharmaceutical composition |
| 09/10/1997 | EP0793965A2 Prophylactic/therapeutic composition for secondary cataract |
| 09/10/1997 | EP0793725A1 Nuclear protein serine/threonine kinases |